Twin Securities’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-91,680
Closed -$4.26M – 16
2023
Q2
$4.26M Buy
+91,680
New +$3.17M 2.36% 7

Twin Securities's DICE Position: Q3 2023 in Review

Twin Securities sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 91,680 shares — an estimated $4.26M sold.

Twin Securities first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $4.26M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • Twin Securities reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Twin Securities sold 91,680 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $4.26M.
  • Twin Securities first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Twin Securities's DICE Therapeutics, Inc. Common Stock position peaked at $4.26M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Twin Securities's 13F filing for Q3 2023, filed 14 Nov 2023.